CN104273413A - 一种野菊花降压含片 - Google Patents
一种野菊花降压含片 Download PDFInfo
- Publication number
- CN104273413A CN104273413A CN201310290758.9A CN201310290758A CN104273413A CN 104273413 A CN104273413 A CN 104273413A CN 201310290758 A CN201310290758 A CN 201310290758A CN 104273413 A CN104273413 A CN 104273413A
- Authority
- CN
- China
- Prior art keywords
- blood pressure
- lozenges
- lowering
- mother chrysanthemum
- wild chrysanthemum
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000007937 lozenge Substances 0.000 title claims abstract description 15
- 230000036772 blood pressure Effects 0.000 title abstract description 16
- 244000035851 Chrysanthemum leucanthemum Species 0.000 title abstract 5
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 title abstract 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 20
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims abstract description 19
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims abstract description 19
- 235000009685 Crataegus X maligna Nutrition 0.000 claims abstract description 19
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims abstract description 19
- 235000009486 Crataegus bullatus Nutrition 0.000 claims abstract description 19
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims abstract description 19
- 235000009682 Crataegus limnophila Nutrition 0.000 claims abstract description 19
- 235000004423 Crataegus monogyna Nutrition 0.000 claims abstract description 19
- 235000002313 Crataegus paludosa Nutrition 0.000 claims abstract description 19
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims abstract description 19
- 244000046146 Pueraria lobata Species 0.000 claims abstract description 16
- 235000010575 Pueraria lobata Nutrition 0.000 claims abstract description 16
- 244000037364 Cinnamomum aromaticum Species 0.000 claims abstract description 15
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims abstract description 15
- 244000179560 Prunella vulgaris Species 0.000 claims abstract description 15
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims abstract description 15
- 235000008113 selfheal Nutrition 0.000 claims abstract description 15
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims abstract description 8
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims abstract description 8
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims abstract description 8
- 229960002675 xylitol Drugs 0.000 claims abstract description 8
- 235000010447 xylitol Nutrition 0.000 claims abstract description 8
- 239000000811 xylitol Substances 0.000 claims abstract description 8
- 238000002360 preparation method Methods 0.000 claims abstract description 7
- 239000005913 Maltodextrin Substances 0.000 claims abstract description 5
- 229920002774 Maltodextrin Polymers 0.000 claims abstract description 5
- 229940035034 maltodextrin Drugs 0.000 claims abstract description 5
- 239000002994 raw material Substances 0.000 claims abstract description 5
- 240000000171 Crataegus monogyna Species 0.000 claims abstract 4
- 240000005250 Chrysanthemum indicum Species 0.000 claims description 25
- 235000018959 Chrysanthemum indicum Nutrition 0.000 claims description 24
- 239000012141 concentrate Substances 0.000 claims description 13
- 238000001914 filtration Methods 0.000 claims description 10
- 239000000463 material Substances 0.000 claims description 9
- 239000002245 particle Substances 0.000 claims description 9
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 claims description 7
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 7
- 238000007598 dipping method Methods 0.000 claims description 7
- 238000001035 drying Methods 0.000 claims description 7
- 239000003826 tablet Substances 0.000 claims description 7
- 239000000843 powder Substances 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 5
- 238000005469 granulation Methods 0.000 claims description 4
- 230000003179 granulation Effects 0.000 claims description 4
- 238000004806 packaging method and process Methods 0.000 claims description 4
- 230000001954 sterilising effect Effects 0.000 claims description 4
- 238000005516 engineering process Methods 0.000 claims description 3
- 239000000706 filtrate Substances 0.000 claims description 3
- 239000008187 granular material Substances 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 239000000314 lubricant Substances 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 239000007779 soft material Substances 0.000 claims description 3
- 238000003809 water extraction Methods 0.000 claims description 3
- 206010020772 Hypertension Diseases 0.000 abstract description 22
- 230000000694 effects Effects 0.000 abstract description 11
- 229910052500 inorganic mineral Inorganic materials 0.000 abstract description 10
- 239000011707 mineral Substances 0.000 abstract description 9
- 201000010099 disease Diseases 0.000 abstract description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 6
- 210000004369 blood Anatomy 0.000 abstract description 5
- 239000008280 blood Substances 0.000 abstract description 5
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract description 5
- 241000411851 herbal medicine Species 0.000 abstract description 4
- 229930006000 Sucrose Natural products 0.000 abstract description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 abstract description 3
- 201000001421 hyperglycemia Diseases 0.000 abstract description 3
- 208000004930 Fatty Liver Diseases 0.000 abstract description 2
- 206010019708 Hepatic steatosis Diseases 0.000 abstract description 2
- 239000002220 antihypertensive agent Substances 0.000 abstract description 2
- 229940127088 antihypertensive drug Drugs 0.000 abstract description 2
- 230000015572 biosynthetic process Effects 0.000 abstract description 2
- 235000012000 cholesterol Nutrition 0.000 abstract description 2
- 229960004106 citric acid Drugs 0.000 abstract description 2
- 235000005911 diet Nutrition 0.000 abstract description 2
- 208000010706 fatty liver disease Diseases 0.000 abstract description 2
- 231100000240 steatosis hepatitis Toxicity 0.000 abstract description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 abstract 2
- 230000004531 blood pressure lowering effect Effects 0.000 abstract 1
- 230000037213 diet Effects 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 235000019359 magnesium stearate Nutrition 0.000 abstract 1
- 229940057948 magnesium stearate Drugs 0.000 abstract 1
- 230000003340 mental effect Effects 0.000 abstract 1
- 206010036067 polydipsia Diseases 0.000 abstract 1
- 230000003449 preventive effect Effects 0.000 abstract 1
- 229960004793 sucrose Drugs 0.000 abstract 1
- 241001092040 Crataegus Species 0.000 description 15
- 235000010755 mineral Nutrition 0.000 description 9
- 208000002173 dizziness Diseases 0.000 description 7
- 235000013619 trace mineral Nutrition 0.000 description 7
- 239000011573 trace mineral Substances 0.000 description 7
- 208000002193 Pain Diseases 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 230000036541 health Effects 0.000 description 5
- 206010019233 Headaches Diseases 0.000 description 4
- 231100000869 headache Toxicity 0.000 description 4
- 230000007774 longterm Effects 0.000 description 4
- 230000002265 prevention Effects 0.000 description 4
- 230000003276 anti-hypertensive effect Effects 0.000 description 3
- 230000036770 blood supply Effects 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 230000001631 hypertensive effect Effects 0.000 description 3
- 206010010741 Conjunctivitis Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 230000002490 cerebral effect Effects 0.000 description 2
- 230000008602 contraction Effects 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 239000002366 mineral element Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 102000008873 Angiotensin II receptor Human genes 0.000 description 1
- 108050000824 Angiotensin II receptor Proteins 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 241000131317 Capitulum Species 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010007572 Cardiac hypertrophy Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 206010057315 Daydreaming Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 102000002045 Endothelin Human genes 0.000 description 1
- 108050009340 Endothelin Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 208000010412 Glaucoma Diseases 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 208000001140 Night Blindness Diseases 0.000 description 1
- 206010034960 Photophobia Diseases 0.000 description 1
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- QGKAVFXNTADNHB-UHFFFAOYSA-N [Mg].[K].[Ca] Chemical compound [Mg].[K].[Ca] QGKAVFXNTADNHB-UHFFFAOYSA-N 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 230000002744 anti-aggregatory effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 235000020682 bottled natural mineral water Nutrition 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000000496 cardiotonic agent Substances 0.000 description 1
- 230000003177 cardiotonic effect Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 229910052729 chemical element Inorganic materials 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 210000003792 cranial nerve Anatomy 0.000 description 1
- MDZKJHQSJHYOHJ-UHFFFAOYSA-N crataegolic acid Natural products C1C(O)C(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MDZKJHQSJHYOHJ-UHFFFAOYSA-N 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 239000003866 digestant Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- ZUBDGKVDJUIMQQ-UBFCDGJISA-N endothelin-1 Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(O)=O)NC(=O)[C@H]1NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@@H](CC=2C=CC(O)=CC=2)NC(=O)[C@H](C(C)C)NC(=O)[C@H]2CSSC[C@@H](C(N[C@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N2)=O)NC(=O)[C@@H](CO)NC(=O)[C@H](N)CSSC1)C1=CNC=N1 ZUBDGKVDJUIMQQ-UBFCDGJISA-N 0.000 description 1
- 210000003038 endothelium Anatomy 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 208000003512 furunculosis Diseases 0.000 description 1
- 230000002650 habitual effect Effects 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- MDZKJHQSJHYOHJ-LLICELPBSA-N maslinic acid Chemical compound C1[C@@H](O)[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MDZKJHQSJHYOHJ-LLICELPBSA-N 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 210000000492 nasalseptum Anatomy 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 230000032696 parturition Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000000467 phytic acid Substances 0.000 description 1
- 229940068041 phytic acid Drugs 0.000 description 1
- 235000002949 phytic acid Nutrition 0.000 description 1
- 230000010349 pulsation Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 210000001202 rhombencephalon Anatomy 0.000 description 1
- 230000001932 seasonal effect Effects 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000000153 supplemental effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
- A23L29/37—Sugar alcohols
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/20—Agglomerating; Granulating; Tabletting
- A23P10/28—Tabletting; Making food bars by compression of a dry powdered mixture
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Botany (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
本发明涉及一种野菊花降压含片的制作,用到的原料主要为野菊花、山楂、葛根、夏枯草、决明子、木糖醇、麦芽糊精、柠檬酸、硬脂酸镁和崂山矿泉水。高血压、高血糖、脂肪肝是现在的流行病,而降血脂、降胆固醇、降血压已成为当下一个热门话题。高血压的成因很多,日常生活不良的饮食习惯,工作压力、生活压力过大和劳累造成精神紧张会引发高血压,过量饮酒与血压升高也关系密切。目前市售的降压药物普遍存在食用、携带不方便的缺点。本发明提供一种野菊花降压含片,集多种有降压活性的中草药的功效于一身,纯天然中草药取材,有很好的预防与辅助降压效果,食用简单、携带方便。含片中用木糖醇取代了蔗糖,适用人群更广。该含片适用于血压偏高的人群服用。
Description
技术领域 本发明涉及一种野菊花降压含片的制作,用到的原料主要为野菊花、山楂、葛根、夏枯草、决明子、木糖醇、麦芽糊精、柠檬酸、硬脂酸镁和崂山矿泉水。高血压、高血糖、脂肪肝是现在的流行病,而降血脂、降胆固醇、降血压已成为当下一个热门话题。高血压的成因很多,日常生活中喜欢吃油腻或口味比较重的人比口味清淡和盐分摄入少的患病几率要高很多;工作压力、生活压力过大和劳累造成精神紧张会引发高血压;个性激烈、脾气暴躁、情绪起伏大的人也更易患高血压;过量饮酒与血压升高也关系密切;长期摄入钙镁钾,膳食纤维不足也会导致血压升高。目前市售的降压药物普遍存在食用、携带不方便的的缺点。本发明提供一种野菊花降压含片,集多种有降压活性的中草药的功效于一身,纯天然中草药取材,有很好的预防与辅助降压效果,食用简单、携带方便。含片中用木糖醇取代了蔗糖,适用人群更广。该含片适用于血压偏高的人群服用。
背景技术现代人的生活不断提高,造成了营养不均衡,饮食结构不合理;既追求吃得精、吃得香。嘴吃香了,身体却受影响了,出现了三高三低症状,产生了高血压、高血脂、高血糖,肥胖人群不断增加。高血压的危害是很严重的。高血压的症状因人而异。早期可能无症状或症状不明显,仅仅会在劳累、精神紧张、情绪波动后发生血压升高,并在休息后恢复正常。随着病程延长,血压明显的持续升高,逐渐会出现各种症状。头晕和头痛是高血压最多见的脑部症状,大部分患者表现为持续性沉闷不适感,经常头晕可妨碍思考,降低工作效率,注意力不集中,记忆力下降,尤以近期记忆力减退为甚。长期的高血压导致脑供血不足,也是引起头晕的原因之一。有些长期血压增高的患者对较高血压已适应,当服降压药将血压降至正常时,也会因脑血管调节的不适应产生头晕。当血压降得太低,有时也会感到头晕,这与脑供血不足有关。头痛可表现为持续性纯痛或搏动性胀痛,甚至有时引起恶心、呕吐,多因血压突然升高使头部血管反射性强烈收缩所致,疼痛的部位可在两侧太阳穴或后脑。另外由于脑神经功能紊乱,可出现烦躁、心悸、失眠、易激动等症状;全身小动脉痉挛以及肢体肌肉供血不足,可导致肢体麻木,颈背肌肉紧张、酸痛;原来鼻中隔部位血管存在缺陷的患者易发生鼻出血。因此急躁的预防和治疗高血压是非常迫切的。本发明提供的这种野菊花降压含片,集合了野菊花、山楂、葛根、夏枯草、决明子的降压功效,是一种适合血压偏高人群食用的绿色保健食品。
发明内容本发明的要点在于将野菊花、山楂、葛根、夏枯草、决明子→漂洗→粉碎→加水热浸提→保温→粗滤→硅藻土过滤机→真空浓缩锅→浓缩液→与其他辅料混合→混合机造粒→干燥→压片→灭菌→包装而成。
本发明选用的材料用量如下(组分及其重量百分比%):野菊花、山楂、葛根、夏枯草、决明子(5:2:1:1:1)浓缩液10.0-20.0;木糖醇50.0-70.0;麦芽糊精10.0-15.0;柠檬酸1.0;硬脂酸镁4‰。
野菊花:野菊花为菊科多年生草本植物野菊的头状花序,外形与菊花相似,野生于山坡草地、田边路旁。以色黄无梗、完整、气香、花未全开者为佳。野菊花含可广泛用于治疗疔疮痈肿、咽喉肿痛、风火赤眼、头痛眩晕等病证。同时又有很好的降压作用,可用于高血压病的辅助治疗。
山楂:山楂能防治心血管疾病,具有扩张血管、强心、增加冠脉血流量、改善心脏活力、兴奋中枢神经系统、降低血压和胆固醇、软化血管及利尿和镇静作用;防治动脉硬化,防衰老、抗癌的作用。山楂酸还有强心作用,对老年性心脏病也有益处。它能开胃消食,特别对消肉食积滞作用更好,很多助消化的药中都采用了山楂;山楂对子宫有收缩作用,在孕妇临产时有催生之效,并能促进产后子宫复原;能增强机体的免疫力,有防衰老、抗癌的作用。山楂中有平喘化痰、抑制细菌、治疗腹痛腹泻的成分。
葛根:最新资料表明,葛根具有α受体和血管紧张素Ⅱ受体亦有阻断作用,疗效优于以往各类抗高血压药物。尤其可能逆转高血压所致的心肌肥厚。葛根素可使明显增高的血浆内皮素(ET)水平较快恢复正常,故葛根素治疗高血压病的机制之一可能在于能抑制ET过量释放,促进内皮恢复功能,进而兴奋PG12合成酶活性,显著增高EC生成PG抑制血小板聚集,起到改善血液循环的作用。大剂量葛根素能降低血糖,能明显降低血清胆固醇。
夏枯草:清肝、散结、利尿;治瘟病、乳痈、目痛、黄疸、淋病、高血压等症;叶可代茶。
决明子:清热明目,润肠通便。用于目赤涩痛,羞明多泪,头痛眩晕,目暗不明,大便秘结。归肝、肾、大肠经。有减肥之功效。治风热赤眼,青盲,雀目,高血压,肝炎,肝硬化腹水,习惯性便秘。
崂山矿泉水:含有丰富的对人体健康有益的常量和微量元素,特别是矿泉水标准中规定的微量元素指标的合理含量,更是对人体起到防病和保健作用。 经科学测定,人体血液中各种化学元素,微量元素平均值与地壳中元素丰度值密切相关,矿泉水是溶解地壳中的矿物元素,所以矿泉水中富含人体所必需的微量元素。从近代生物化学、量子化学及结构物理学研究证明,水中矿物质和微量元素对人体生命与健康是不能缺少的,是不能用食物中的矿物质和微量元素完全取代的,水中的矿物质和微量元素是离子态,容易被人体所吸收,其吸收高达90%以上,而且吸收的快。食物中的矿物质和微量元素,由于植物纤维和植酸的影响,吸收率多数不到30%,有的仅为10%以下。所以饮用含有矿物质和微量元素的天然矿泉水有益健康。另外还特别值得提出的是:水中pH值对人体健康也是重要因素,人体体液呈弱碱性,pH值范围在7.3~7.45。矿泉水属弱碱性,pH值一般在7.5左右,与人体体液的pH值相吻合,有利于维持正常的渗透压和酸碱平衡,促进新陈代谢。
本发明生产工艺: 野菊花、山楂、葛根、夏枯草、决明子→漂洗→粉碎→加水热浸提→保温→粗滤→硅藻土过滤机→真空浓缩锅→浓缩液→与其他辅料混合→混合机造粒→干燥→压片→灭菌→包装。
本发明产品的制备方法是:
1)预处理:野菊花、山楂、葛根、夏枯草、决明子洗净、切碎、烘干,粉碎机破碎成细粉;
2)热浸提取:将原材料细粉放入夹层锅中,加30倍的崂山矿泉水,热水浸提(90-100度)并保温4小时;
3)过滤:先用60目滤网粗滤,再经过硅藻土过滤机进行细滤;
4)浓缩:把滤液输入真空浓缩锅(真空度97kPa,温度55左右),将液体浓缩至原加水量1/20时,成为浓缩液;
5)将浓缩液和其他辅料按一定比例充分混合;
6)混合充分的软料投入摇摆式颗粒剂中进行造成粒,再把颗粒放在真空干燥机中进行干燥,真空度控制在0.053-0.060Mpa,温度控制在60-65度使颗粒的水分控制在小于3%左右;
7)在干燥颗粒中加入润滑剂(硬脂酸镁,4‰)混匀后,压片,紫外线下照射30分钟,然后及时包装。
本发明具有以下优点:
1) 集合了野菊花、山楂、葛根、夏枯草、决明子的降压功效,效果显著;
2)食用简单,携带方便;
3)质量优,长期食用无副作用;
4)木糖醇取代了蔗糖,适用人群更广。
具体实施方式:下面结合实施例对本发明作进一步的详细说明:
以100kg本发明产品为例:
1.配方:(组分及其重量百分比%):野菊花、山楂、葛根、夏枯草、决明子(5:2:1:1:1)浓缩液10.0-20.0;木糖醇50.0-70.0;麦芽糊精10.0-15.0;柠檬酸1.0;硬脂酸镁4‰。
2. 生产流程: 野菊花、山楂、葛根、夏枯草、决明子→漂洗→粉碎→加水热浸提→保温→粗滤→硅藻土过滤机→真空浓缩锅→浓缩液→与其他辅料混合→混合机造粒→干燥→压片→灭菌→包装。
3.制备方法:
1)预处理:野菊花、山楂、葛根、夏枯草、决明子洗净、切碎、烘干,粉碎机破碎成细粉;
2)热浸提取:将原材料细粉放入夹层锅中,加30倍的崂山矿泉水,热水浸提(90-100度)并保温4小时;
3)过滤:先用60目滤网粗滤,再经过硅藻土过滤机进行细滤;
4)浓缩:把滤液输入真空浓缩锅(真空度97kPa,温度55左右),将液体浓缩至原加水量1/20时,成为浓缩液;
5)将浓缩液和其他辅料按一定比例充分混合;
6)混合充分的软料投入摇摆式颗粒剂中进行造成粒,再把颗粒放在真空干燥机中进行干燥,真空度控制在0.053-0.060Mpa,温度控制在60-65度使颗粒的水分控制在小于3%左右;
7)在干燥颗粒中加入润滑剂(硬脂酸镁,4‰)混匀后,压片,紫外线下照射30分钟,然后及时包装。
Claims (3)
1.本发明涉及一种野菊花降压含片的制作方法,其特征在于具有如下配方(组分及其重量百分比%):
野菊花、山楂、葛根、夏枯草、决明子(5:2:1:1:1)浓缩液10.0-20.0;木糖醇50.0-70.0;麦芽糊精10.0-15.0;柠檬酸1.0;硬脂酸镁4‰。
2. 一种权利要求1所述的野菊花降压含片的制作方法,其特征在于具有如下的生产工艺:
野菊花、山楂、葛根、夏枯草、决明子→漂洗→粉碎→加水热浸提→保温→粗滤→硅藻土过滤机→真空浓缩锅→浓缩液→与其他辅料混合→混合机造粒→干燥→压片→灭菌→包装。
3. 一种权利要求1所述的野菊花降压含片的制作方法,其特征在于具有如下的制备方法:
1)预处理:野菊花、山楂、葛根、夏枯草、决明子洗净、切碎、烘干,粉碎机破碎成细粉;
2)热浸提取:将原材料细粉放入夹层锅中,加30倍的崂山矿泉水,热水浸提(90-100度)并保温4小时;
3)过滤:先用60目滤网粗滤,再经过硅藻土过滤机进行细滤;
4)浓缩:把滤液输入真空浓缩锅(真空度97kPa,温度55左右),将液体浓缩至原加水量1/20时,成为浓缩液;
5)将浓缩液和其他辅料按一定比例充分混合;
6)混合充分的软料投入摇摆式颗粒剂中进行造成粒,再把颗粒放在真空干燥机中进行干燥,真空度控制在0.053-0.060Mpa,温度控制在60-65度使颗粒的水分控制在小于3%左右;
7)在干燥颗粒中加入润滑剂(硬脂酸镁,4‰)混匀后,压片,紫外线下照射30分钟,然后及时包装。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310290758.9A CN104273413A (zh) | 2013-07-11 | 2013-07-11 | 一种野菊花降压含片 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310290758.9A CN104273413A (zh) | 2013-07-11 | 2013-07-11 | 一种野菊花降压含片 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104273413A true CN104273413A (zh) | 2015-01-14 |
Family
ID=52249153
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310290758.9A Pending CN104273413A (zh) | 2013-07-11 | 2013-07-11 | 一种野菊花降压含片 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104273413A (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106072645A (zh) * | 2016-06-29 | 2016-11-09 | 傅志勇 | 治疗三高的保健品及其制备方法与应用 |
CN107213183A (zh) * | 2017-05-12 | 2017-09-29 | 安徽菊泰滁菊草本科技有限公司 | 一种菊花含片的制作方法 |
CN112369584A (zh) * | 2020-11-11 | 2021-02-19 | 湖南味了谁食品有限责任公司 | 一种低辣度的剁辣椒及其生产工艺 |
-
2013
- 2013-07-11 CN CN201310290758.9A patent/CN104273413A/zh active Pending
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106072645A (zh) * | 2016-06-29 | 2016-11-09 | 傅志勇 | 治疗三高的保健品及其制备方法与应用 |
CN107213183A (zh) * | 2017-05-12 | 2017-09-29 | 安徽菊泰滁菊草本科技有限公司 | 一种菊花含片的制作方法 |
CN112369584A (zh) * | 2020-11-11 | 2021-02-19 | 湖南味了谁食品有限责任公司 | 一种低辣度的剁辣椒及其生产工艺 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102763884B (zh) | 番石榴保健饮料及其制备方法 | |
KR101090284B1 (ko) | 홍삼과 녹용 추출물을 포함하는 드링크제 및 그의 제조방법 | |
CN102302072B (zh) | 一种解酒护肝的保健茶及其制备方法 | |
CN102697047B (zh) | 一种枸杞口服液的制备方法 | |
CN104256008A (zh) | 山楂决明子茶及其制备方法 | |
CN109123296A (zh) | 葛根桑叶复合固体饮料及制备方法 | |
CN103431115A (zh) | 一种保健茶及其制备方法 | |
CN109730180A (zh) | 一种降血压、降血脂、降血糖组合物及其制备方法和袋泡茶 | |
CN103719660A (zh) | 一种韩国高丽红参切片蜜片的加工工艺 | |
CN104323153A (zh) | 降三高保健食品 | |
CN1742931A (zh) | 玉竹决明冲剂及其制备工艺 | |
CN104273413A (zh) | 一种野菊花降压含片 | |
CN103461585A (zh) | 补气养生中药茶 | |
CN105907458A (zh) | 一种三高人群适用的保健芝麻油及其制备方法 | |
CN103725555A (zh) | 一种辅助降血压的野生芭蕉及牛角蕉保健酒及其制备方法 | |
CN109170014A (zh) | 一种石斛保健茶及其制备方法 | |
CN102106577A (zh) | 天然有机可提高男性睡眠质量的饮料 | |
CN104365921A (zh) | 一种睡莲速溶降压茶的制作方法 | |
CN103463456B (zh) | 一种中药组合物及其制备方法 | |
CN103461779B (zh) | 多功能绿色杂粮食品 | |
CN108114222A (zh) | 一种补气健脾滋补肝肾的中药组合物及其制备方法 | |
CN106538795A (zh) | 烟霾清茶 | |
CN104366179A (zh) | 一种睡莲健胃含片的制作方法 | |
CN104367969A (zh) | 一种睡莲健胃胶囊 | |
CN104664505A (zh) | 一种改善睡眠的饮料 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20150114 |